Surgical Science Financials
| 0AAU Stock | 144.90 0.30 0.21% |
Operating Margin 0.1476 | PE Ratio 0.6613 | Profit Margin 0.2359 | Return On Equity 0.0436 |
Surgical | Select Account or Indicator |
Understanding current and past Surgical Science Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Surgical Science's financial statements are interrelated, with each one affecting the others. For example, an increase in Surgical Science's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Surgical Science's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgical Science Sweden. Check Surgical Science's Beneish M Score to see the likelihood of Surgical Science's management manipulating its earnings.
Surgical Science Stock Summary
Surgical Science competes with Samsung Electronics, Samsung Electronics, Hyundai, Toyota, and MOL Hungarian. Surgical Science is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Industrials, Commercial & Professional Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| Business Address | Drakegatan 7 A, |
| Sector | Commercial Services & Supplies |
| Industry | Industrials |
| Benchmark | Dow Jones Industrial |
| Website | www.surgicalscience.com |
| Phone | 46 3 17 41 65 60 |
You should never invest in Surgical Science without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Surgical Stock, because this is throwing your money away. Analyzing the key information contained in Surgical Science's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Surgical Science Key Financial Ratios
There are many critical financial ratios that Surgical Science's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Surgical Science Sweden reports annually and quarterly.| Net Income | 233.97 M | ||||
| Retained Earnings | 273.79 M |
Surgical Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgical Science's current stock value. Our valuation model uses many indicators to compare Surgical Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgical Science competition to find correlations between indicators driving Surgical Science's intrinsic value. More Info.Surgical Science Sweden is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Surgical Science Sweden is roughly 2.24 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgical Science's earnings, one of the primary drivers of an investment's value.Surgical Science Sweden Systematic Risk
Surgical Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surgical Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Surgical Science Sweden correlated with the market. If Beta is less than 0 Surgical Science generally moves in the opposite direction as compared to the market. If Surgical Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surgical Science Sweden is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surgical Science is generally in the same direction as the market. If Beta > 1 Surgical Science moves generally in the same direction as, but more than the movement of the benchmark.
Surgical Science Sweden Other Current Liab Over Time
Surgical Science November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Surgical Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surgical Science Sweden. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surgical Science Sweden based on widely used predictive technical indicators. In general, we focus on analyzing Surgical Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surgical Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.56 | |||
| Information Ratio | 0.0257 | |||
| Maximum Drawdown | 14.92 | |||
| Value At Risk | (4.15) | |||
| Potential Upside | 5.69 |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.